Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
65
datasets available to search
ShareScore release 0.9.0
Dataset results
65 results for “Risk Tolerance”
"Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"
ClinicalTrials.gov study NCT05761509. IPD Sharing: NO. Countries: 1. Publications: 7.
Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02319369. IPD Sharing: YES. Countries: 1. Publications: 0.
Tolerability and Risk of Adverse Events With a Probiotic Supplement
ClinicalTrials.gov study NCT03728868. IPD Sharing: NO. Countries: 1. Publications: 12.
Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer
ClinicalTrials.gov study NCT03838263. IPD Sharing: YES. Countries: 1. Publications: 0.
First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
ClinicalTrials.gov study NCT05601726. IPD Sharing: NO. Countries: 1. Publications: 1.
Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis
ClinicalTrials.gov study NCT05229640. IPD Sharing: NO. Countries: 1. Publications: 5.
A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.
ClinicalTrials.gov study NCT05524051. IPD Sharing: YES. Countries: 15. Publications: 0.
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
ClinicalTrials.gov study NCT06286488. IPD Sharing: NO. Countries: 1. Publications: 1.
Data from: A survey of risk tolerance to multiple sclerosis therapies
Open the record for dataset details and reuse information.
Self Efficacy and Risk Tolerance
<p>This includes tally results for self efficacy and risk tolerance of stock investors in Baguio City</p>
Data from: Life-history strategy and behavioral type: risk-tolerance reflects growth rate and energy allocation in ant colonies
Despite the recent interest in animal personality and behavioral syndromes, there is a paucity of explanations for why distinct behavioral traits should evolve to correlate. We investigate whether such correlations across apparently distinct behavioral traits may be explained by variation in life history strategy among individual ant colonies. Life history theory predicts that the way in which individuals allocate energy towards somatic maintenance or reproduction drives several distinct traits in physiology, morphology, and energy use; it also predicts that an individual's willingness to engage in risky behaviors should depend on reproductive strategy. We use Temnothorax ants, which have been shown to exhibit 'personalities' and a syndrome that may reflect risk tolerance at the colony level. We measure colonies' relative investment in growth rate (new workers produced) compared to reproductive effort (males and queens produced). Comparing sterile worker production to reproductive alate production provides a direct measure of how colonies are investing their energy, analogous to investment in growth versus reproduction in a unitary organism. Consistently with this idea, we found that behavioral type of ant colonies was associated with their life history strategy: risk-tolerant colonies grew faster and invested more in reproduction, whereas risk-averse colonies had lower growth rate but invested relatively more in workers. This provides evidence that behavioral syndromes can be a consequence of life-history strategy variation, linking the two fields and supporting the use of an integrative approach.
A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor
ClinicalTrials.gov study NCT06024408. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
ClinicalTrials.gov study NCT03433781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus
ClinicalTrials.gov study NCT01079195. IPD Sharing: Not stated. Countries: 7. Publications: 0.
An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event
ClinicalTrials.gov study NCT03099213. IPD Sharing: YES. Countries: 1. Publications: 0.
Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled S
ClinicalTrials.gov study NCT02078167. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)
ClinicalTrials.gov study NCT00685776. IPD Sharing: Not stated. Countries: 0. Publications: 4.
A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (M
ClinicalTrials.gov study NCT04079296. IPD Sharing: NO. Countries: 2. Publications: 0.
Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study
ClinicalTrials.gov study NCT01099397. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD)
ClinicalTrials.gov study NCT06673069. IPD Sharing: YES. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.